top of page
Clients' testimonials
02:57
02:34
Blog
IDENTIFYING THE ROOT CAUSE OF A LOW RECRUITMENT RATE ANDREVERSING THE TREND
Dose-escalation phase I/II study in patients with glioblastoma PRODUCT TYPE Small molecule THERAPEUTIC AREA Oncology – solid tumours...
TRAINING & UPSKILLING TO IMPROVE CLINICAL TRIAL OUTCOME
An open-label, multicenter, non-randomized interventional roll over trial for relapsing glioblastoma patients
RESCUING AN EXTENSION PHASE
A randomized, double blind, multicentre, multinational, placebo controlled, single parallel escalating dose safety and efficacy study
bottom of page